EAEdna Motta Almodin

Edna Motta Almodin

*This is an algorithmically generated author record based on publicly available information.

Edna Motta Almodin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Response to: Corneal collagen cross-linking by sun exposure and high dose oral riboflavin: a multicentric longitudinal observational study

    by Edna Almodin, Flávia Almodin, Juliana Almodin

    Dear Editor, We appreciate your thoughtful review of our recently published article. We fully agree that the ideal way to evaluate the potential of oral riboflavin combined with sun exposure would be through a prospective, controlled, large-scale study involving patients with documented progressive keratoconus. Only then would it be possible to unequivocally distinguish the effect of the intervention from natural variability, spontaneous stability, or co-interventions. […] Response to: Corneal collagen cross-linking by sun exposure and high dose oral riboflavin: a [...] Dear Editor, We appreciate your thoughtful review of our recently published article. We fully agree that the ideal way to evaluate the potential of oral riboflavin combined with sun exposure would be through a prospective, controlled, large-scale study involving patients with documented progressive keratoconus. Only then would it be possible to unequivocally distinguish the effect of the intervention from natural variability, spontaneous stability, or co-interventions. […] Response to: Corneal collagen cross-linking by sun exposure and high dose oral riboflavin: a

  • Open Access

    Corneal collagen cross-linking by sun exposure and high dose oral riboflavin: a multicentric longitudinal observational study

    by Edna Motta Almodin, Flávia Almodin, Juliana Almodin

    Objective: To evaluate the efficacy of high-dose oral riboflavin treatment combined with sun exposure in preventing the progression of keratoconus. Methods: A retrospective, multicenter observational study involving 53 keratoconus patients (106 eyes) from three Brazilian cities. Patients were instructed to take 400 mg/day of oral riboflavin and to sunbathe for 30 minutes daily, in addition to avoiding eye rubbing. Keratometric measurements were evaluated before and after 6, 12, 24, and 36 months of treatment. Results: After 6 months, 42 [...] ABSTRACT Objective: To evaluate the efficacy of high-dose oral riboflavin treatment combined with sun exposure in preventing the progression of keratoconus. Methods: A retrospective, multicenter observational study involving 53 keratoconus patients (106 eyes) from three Brazilian cities. Patients were instructed to take 400 mg/day of oral riboflavin and to sunbathe for 30 minutes daily, in addition to avoiding eye rubbing. Keratometric measurements were evaluated before and after 6, 12, 24, and 36 months of treatment. Results: After 6 months, 42


  • Effects of the excessive use of electronic screens on vision and emotional state

    by Viviane Fernanda da Silva Barros, Raissa Adriana da Silva Gomes de Oliveira, Robson Borges Maia, Nilma Fernandes, Edna Motta Almodin

    Objective To investigate relations between electronic screen use and eye health in a representative sample of the Brazilian population. Methods Data were collected online and analyzed at a private Brazilian hospital (Provisão Hospital, Maringá, Brazil). Male and female individuals aged 12 to 35 years participated in the study. A population-based cross-sectional survey based on a questionnaire developed using the Google Forms interface was carried out. The questionnaire was answered anonymously in order to ensure the confidentiality of data and [...] ABSTRACT Objective To investigate relations between electronic screen use and eye health in a representative sample of the Brazilian population. Methods Data were collected online and analyzed at a private Brazilian hospital (Provisão Hospital, Maringá, Brazil). Male and female individuals aged 12 to 35 years participated in the study. A population-based cross-sectional survey based on a questionnaire developed using the Google Forms interface was carried out. The questionnaire was answered anonymously in order to ensure the confidentiality of data and


  • Intrastromal implantation of chicken corneal grafts into the cornea of rabbits for corneal thickening: an experimental study

    by Flavia Motta Almodin, Juliana Motta Almodin, Edna Motta Almodin, Nilma Fernandes, Paulo Ferrara, Antonio Gonçalves

    Purpose To evaluate the feasibility and effects of the intrastromal implantation of chemically modified corneal stroma obtained from chicken into the corneas of rabbits for corneal thickening. Methods Chicken corneas were cut, debrided, treated with cross-linking and implanted in an intrastromal pouch created in the cornea of 10 white New Zealand rabbits with femtosecond laser. Slit-lamp biomicroscopy and optical coherence tomography were performed immediately, 7, 30 and 90 days postoperatively. Corneas were removed at 90 days and cut in two halves. One half was sent to histological analysis for the presence of necrosis, polymorphonuclear inflammatory cells, blood vessels and fibrosis, while the other half was evaluated with transmission electron microscopy to verify tissue organization and the presence of keratocytes and inflammatory cells. Corneal thicknesses were comparatively analyzed over time with Wilcoxon test (p ≤ 0.05). Results The chicken grafts were incorporated into the cornea of all animals over time. Mean rabbit cornea thickness increased from 338 µm preoperatively to 538 µm (p < 0.0077) at 90 days, while mean chicken graft thickness decreased from 350 to 215 µm (p < 0.0077). No clear signs of rejection attributable to the xenograft were observed in any of the implanted eyes. However, some macroscopic and histological events were observed in some of the eyes, probably due to procedural issues during implantation. Conclusion The intrastromal implantation of chicken grafts was shown to be feasible and predictable to thicken the recipient rabbit cornea without apparent rejection. However, before being considered in humans, further meticulous clinical trials are required to establish the clinical utility, safety and efficacy of xenografts for the treatment of patients with advanced keratoconus.